Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Animal Model Evidence The systemic evidence base is entirely preclinical: Pulmonary fibrosis (mouse model): Intraperitoneal GHK-Cu at 0.2-20 micrograms/g/day protected against bleomycin-induced lung fibrosis by inhibiting TGF-beta1/Smad signaling and reducing oxidative stress (PMID 31809714)
No apto para consumo humano
Shields Compounding Pharmacy
(2023) Phase 2 CagriSema combination, Lancet Novo Nordisk REDEFINE 1 Phase 3 results (2025) European Medicines Agency MHRA Medically reviewed by Mohammed Lakhi Superintendent Pharmacist
For targeted healing (wound recovery, scar reduction), inject as close to the target area as practical
US$ 26.30
US$ 28.02
US$ 20.43
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
US$ 29.58
